TP53 and gastric neoplasm: Consistent with previous genomic characterization of gastric cancers based on molecular classification, we observed enrichments of PIK3CA and TP53 somatic mutations in EBV-positive and HCNA-subtype gastric tumors, respectively, whereas CDH1 and NF1 aberrations were evident in genomically stable (LCNA) tumors.